Neurogati

Neurogati operates at the intersection of neurotechnology, digital health, diagnostics, and AI/ML. Its stated scope spans neurological assessment, rehabilitation, and assistive technology rather than a single narrow clinical workflow. Quadis-PD™ is the clearest named product: it is described as supporting diagnosis, monitoring, and rehabilitation for Parkinson’s disease. Its stated differentiators include computational neuroscience, clinical expertise, standardized data-driven motor and cognitive assessments, and gamified rehabilitation intended to support engagement. Funding stage and investor backing are also unknown. Neurogati’s market position is therefore best characterized by its breadth of intended neurological-care applications and its named Parkinson’s platform, rather than by a verified competitive ranking or evidence of scale.

Neurogati’s visible growth story is centered on a portfolio of neurological-care technologies rather than documented financing or headcount expansion. The named product set includes Quadis-PD™, focused on Parkinson’s diagnosis, monitoring, and rehabilitation, as well as SparshBharati™, MudhraBharati™, and NodText™. The company describes its approach as combining AI and computational neuroscience with assessment, gamified therapy, and assistive technology. The current hiring signal indicates no active openings, while recent layoffs are reported as false.